Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.
The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.
